HSBC Holdings
EWTX icon

HSBC Holdings’s Edgewise Therapeutics EWTX Stock Holding History

HSBC Holdings’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Buy
+91,638
New +$3.16M ﹤0.01% 1328
2025
Q3 		– Sell
-10,712
Closed -$142K – 2829
2025
Q2 		$142K Buy
10,712
+838
+8% +$12.1K ﹤0.01% 2778
2025
Q1 		$219K Sell
9,874
-885
-8% -$23.2K ﹤0.01% 2575
2024
Q4 		$283K Buy
10,759
+2,031
+23% +$64.7K ﹤0.01% 2528
2024
Q3 		$228K Buy
+8,728
New +$174K ﹤0.01% 2531

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HSBC Holdings's EWTX Position: Q2 2026 in Review

HSBC Holdings opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 91,638 shares worth $3.72M. The stake represents ﹤0.01% of the portfolio and ranks #1328 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in EWTX as recently as Q2 2025.

HSBC Holdings first reported a position in EWTX in Q3 2024 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • HSBC Holdings held 91,638 shares of Edgewise Therapeutics worth $3.72M as of Q2 2026.
  • Edgewise Therapeutics was a new HSBC Holdings position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1328 holding.
  • HSBC Holdings first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.